key: cord-0838598-7bh6vjzv authors: Birabaharan, Morgan; Kaelber, David C.; Karris, Maile Y. title: Risk of Herpes Zoster Reactivation After mRNA COVID-19 Vaccination: A Cohort Study date: 2021-11-23 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2021.11.025 sha: 5c4075bf824f6d557b99b3cd0fb084b434832dc1 doc_id: 838598 cord_uid: 7bh6vjzv nan Recent case series and media coverage suggest an association between receiving the mRNA 39 COVID-19 vaccine and reactivation of varicella zoster virus (VZV) [1] [2] [3] . Fear of a potential 40 adverse effect will drive vaccine refusal and subsequent preventable disease and death. The 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 J o u r n a l P r e -p r o o f Cutaneous reactions reported after 91 Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory 95 rheumatic diseases: a case series Varicella-zoster virus reactivation 97 after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases Herpes zoster and postherpetic 100 neuralgia surveillance using structured electronic data Seasonal variation in herpes zoster infection